Impact of Cell-surface Antigen Expression on Target Engagement and Function of an Epidermal Growth Factor Receptor ×
Stephen W Jarantow1, Barbara S Bushey1, Jose R Pardinas1
1From Janssen Research and Development, LLC, Spring House, Pennsylvania 19477 and.
Abstract:
The efficacy of engaging multiple drug targets using bispecific antibodies (BsAbs) is affected by the relative cell-surface protein levels of the respective targets. In this work, the receptor density values were correlated to the in vitro activity of a BsAb (JNJ-61186372) targeting epidermal growth factor receptor (EGFR) and hepatocyte growth factor receptor (c-MET). Simultaneous binding of the BsAb to both receptors was confirmed in vitro. By using controlled Fab-arm exchange, a set of BsAbs targeting EGFR and c-MET was generated to establish an accurate receptor quantitation of a panel of lung and gastric cancer cell lines expressing heterogeneous levels of EGFR and c-MET. EGFR and c-MET receptor density levels were correlated to the respective gene expression levels as well as to the respective receptor phosphorylation inhibition values. We observed a bias in BsAb binding toward the more highly expressed of the two receptors, EGFR or c-MET, which resulted in the enhanced in vitro potency of JNJ-61186372 against the less highly expressed target. On the basis of these observations, we propose an avidity model of how JNJ-61186372 engages EGFR and c-MET with potentially broad implications for bispecific drug efficacy and design.
Insights
Bispecific antibodies (BsAbs) efficacy depends on target protein levels. This study shows BsAb JNJ-61186372 binding favors higher expressed targets (EGFR/c-MET), enhancing potency against lower expressed targets.
Area of Science:
- Oncology
- Immunology
- Pharmacology
Background:
- Bispecific antibodies (BsAbs) engage multiple targets, but efficacy is influenced by relative cell-surface protein levels.
- Understanding target receptor density is crucial for optimizing BsAb therapy.
Purpose of the Study:
- To correlate receptor density with the in vitro activity of a BsAb targeting epidermal growth factor receptor (EGFR) and hepatocyte growth factor receptor (c-MET).
- To investigate the binding bias of BsAbs towards differentially expressed cell-surface receptors.
Main Methods:
- Utilized controlled Fab-arm exchange to generate BsAbs targeting EGFR and c-MET.
- Quantified EGFR and c-MET receptor density in lung and gastric cancer cell lines.
- Correlated receptor density with gene expression and phosphorylation inhibition.
Main Results:
- Confirmed simultaneous binding of BsAb JNJ-61186372 to EGFR and c-MET in vitro.
- Observed BsAb binding bias towards the more highly expressed receptor (EGFR or c-MET).
- Demonstrated enhanced in vitro potency against the less highly expressed target.
Conclusions:
- Proposed an avidity model for BsAb engagement of EGFR and c-MET.
- Highlighted implications for bispecific drug efficacy and design based on receptor expression levels.
More Related Videos
10:46A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
Published on: September 13, 2022
13:19Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
Published on: April 26, 2024
Related Concept Videos
Mitogens and the Cell Cycle
Targeted Cancer Therapies
There are several types of targeted therapies against...
